Trials / Completed
CompletedNCT02195921
Acupuncture for Chemotherapy-Induced Nausea and Vomiting
Acupuncture for Chemotherapy-Induced Nausea and Vomiting: A Randomized Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Tianjin University of Traditional Chinese Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to clarify whether the matching acupoints is more effective than a single point by electroacupuncture in the management of chemotherapy-induced nausea and vomiting .
Detailed description
Patients were assigned to Four sessions of electroacupuncture(EA) at the CV12, ST36, CV12+ST36 acupoints or antiemetic therapy over 5 days. primary and secondary outcomes and Adverse Eventswill be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | single point Zhongwan(CV12) plus antiemetic drug | All participants were supine in the hospital bed. A disposable sterile acupuncture needle (ø 0.30 × 40 mm, Hwato) was inserted vertically at approximately 20-30 mm until "De Qi" (sensation of soreness, numbness, distension, etc. around the acupoint) was reported by the participants. Then, the needle handle was clamped via a metal clip to connect to the positive electrode of the electric acupuncture apparatus (Huatuo, SDZ-V model, Suzhou Medical Appliance). Another reference electrode was placed 1 cm above the CV12 acupoints of the stimulation point, where no acupoints or meridians passed through. A dilatational wave at a frequency of 2/10 Hz and a current intensity at the highest level tolerated by the patient, with a maximum intensity no more than 10 mA, were used to deliver the EA stimulation. People in the intervention groups were offered a standardized 30-minute EA session once daily from the 1st day of the four-day chemotherapy cycle. |
| OTHER | single point Zusanli(ST36) plus antiemetic drug | A disposable sterile acupuncture needle (ø 0.30 × 40 mm, Hwato) was inserted vertically at approximately 20-30 mm until "De Qi" (sensation of soreness, numbness, distension, etc. around the acupoint) was reported by the participants. Then, the needle handle was clamped via a metal clip to connect to the positive electrode of the electric acupuncture apparatus (Huatuo, SDZ-V model, Suzhou Medical Appliance). Another reference electrode was placed 1cm below ST36 acupoints of the stimulation point, respectively, where no acupoints or meridians passed through. A dilatational wave at a frequency of 2/10 Hz and a current intensity at the highest level tolerated by the patient, with a maximum intensity no more than 10 mA, were used to deliver the EA stimulation. People in the intervention groups were offered a standardized 30-minute EA session once daily from the 1st day of the four-day chemotherapy cycle. |
| OTHER | Zusanli(ST36)and Zhongwan(CV12) plus antiemetic drug | Stimulating both Zusanli(ST36)and Zhongwan(CV12) |
| DRUG | only antiemetic drug | received routine antiemetic treatment |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-03-01
- Completion
- 2017-01-01
- First posted
- 2014-07-21
- Last updated
- 2021-02-11
- Results posted
- 2021-02-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02195921. Inclusion in this directory is not an endorsement.